Patent · US Expired

Use for bis-heterocyclic compounds and pharmaceutical compositions containing same

US5496950A · kind A · utility

5Cited by
3References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 28, 1994
Grant dateMar 5, 1996
Priority date
Expiry dateOct 28, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A novel use for the class of biologically active bis-heterocyclic, e.g., bis-indole alkaloid compounds, which have been named topsentins, nortopsentins, hamacanthins, or dragmacidins, pharmaceutical compositions containing them, methods of producing the compounds, and methods of using the compounds are disclosed. Specifically, the novel utility pertains to the anti-inflammatory properties exhibited by the bis-indole compounds and their analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.